At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals
- Mechanism of Action Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 13 Feb 2001 Profile reviewed but no significant changes made
- 29 Jul 1998 No-Development-Reported for Influenza virus infections in USA (Parenteral)
- 21 Jun 1996 New profile